Home > Cashflow Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-441 Cr₹-422 Cr₹818 Cr₹794 Cr₹3,977 Cr

What is the latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA ?

The latest Cash Flow from Financing Activities ratio of PIRAMAL PHARMA is ₹-441 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-441 Cr
Mar2024₹-422 Cr
Mar2023₹818 Cr
Mar2022₹794 Cr
Mar2021₹3,977 Cr

How is Cash Flow from Financing Activities of PIRAMAL PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-441 Cr
Negative
Mar2024 ₹-422 Cr
Negative
Mar2023 ₹818 Cr
2.97
Mar2022 ₹794 Cr
-80.03
Mar2021 ₹3,977 Cr -

Compare Cash Flow from Financing Activities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹18,755.0 Cr -5% -15.2% -39.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹100,480.0 Cr -3.9% -9.1% -18.4% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-5%

-15.2%

-39.1%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses